ENTRY       D01111                      Drug
NAME        Nateglinide (JP18/USP/INN);
            Starsis (TN)
PRODUCT
  GENERIC   NATEGLINIDE (Actavis Pharma)
            NATEGLINIDE (American Health Packaging)
            NATEGLINIDE (American Health Packaging)
            NATEGLINIDE (Cadila Pharmaceuticals Limited)
            NATEGLINIDE (Dr. Reddy's Laboratories Limited)
            NATEGLINIDE (Golden State Medical Supply)
            NATEGLINIDE (Golden State Medical Supply)
            NATEGLINIDE (Modavar Pharmaceuticals LLC)
            NATEGLINIDE (Nivagen Pharmaceuticals)
            NATEGLINIDE (Par Pharmaceutical)
            NATEGLINIDE (Rising Pharmaceuticals)
            NATEGLINIDE (Strides Pharma Science Limited)
            NATEGLINIDE (Zydus Lifesciences Limited)
            NATEGLINIDE (Zydus Pharmaceuticals (USA))
FORMULA     C19H27NO3
EXACT_MASS  317.1991
MOL_WEIGHT  317.4226
CLASS       Antidiabetic agent
             DG01508  Sulfonylurea receptor agonist
              DG01735  Glinide
             DG02044  Hypoglycemic agent
              DG01735  Glinide
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
REMARK      Same as: C12508
            Therapeutic category: 3969
            ATC code: A10BX03
            Product: D01111<JP/US>
EFFICACY    Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     Glinide derivative
            Treatment of Type II diabetes mellitus
TARGET      ABCC8(SUR1)/KCNJ11(KIR6.2) [HSA:6833 3767] [KO:K05032 K05004]
  PATHWAY   hsa02010(6833)  ABC transporters
            hsa04911(3767+6833)  Insulin secretion
            hsa04930(3767+6833)  Type II diabetes mellitus
METABOLISM  Enzyme: CYP2C9 [HSA:1559]
INTERACTION  
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BX Other blood glucose lowering drugs, excl. insulins
                 A10BX03 Nateglinide
                  D01111  Nateglinide (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Agents
               Glucose Control Agents, Other
                Nateglinide
                 D01111  Nateglinide (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               396  Antidiabetic agents
                3969  Others
                 D01111  Nateglinide (JP18/USP/INN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG01508  Sulfonylurea receptor agonist
               DG01735  Glinide
                D01111  Nateglinide
              DG02044  Hypoglycemic agent
               DG01735  Glinide
                D01111  Nateglinide
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D01111  Nateglinide
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01735  Glinide
               D01111  Nateglinide
              DG02044  Hypoglycemic agent
               D01111  Nateglinide
            Target-based classification of drugs [BR:br08310]
             Transporters
              ABC transporters
               ABCC subfamily
                ABCC8(SUR1)/KCNJ11(KIR6.2)
                 D01111  Nateglinide (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01111  Nateglinide
              D01111  Nateglinide tablets
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01111
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01111
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01111
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01111
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D01111
DBLINKS     CAS: 105816-04-4
            PubChem: 7848174
            ChEBI: 31897
            LigandBox: D01111
            NIKKAJI: J259.863I J263.263B
ATOM        23
            1   C1b C    21.1279  -14.8259
            2   C1c C    21.1279  -16.2406
            3   C6a C    22.3304  -16.9480
            4   O6a O    22.3304  -18.3627
            5   O6a O    23.4622  -16.3114
            6   N1b N    19.8547  -16.9480
            7   C8y C    22.3304  -14.1186
            8   C8x C    22.3304  -12.7039
            9   C8x C    23.4622  -11.9965
            10  C8x C    24.7354  -12.7039
            11  C8x C    24.7354  -14.1186
            12  C8x C    23.5329  -14.8259
            13  C5a C    18.6522  -16.2406
            14  C1y C    17.3789  -16.8772
            15  O5a O    18.6522  -14.8259
            16  C1x C    17.3789  -18.2919
            17  C1x C    16.1764  -18.9993
            18  C1y C    14.9740  -18.2212
            19  C1x C    14.9740  -16.8772
            20  C1x C    16.1764  -16.1699
            21  C1c C    13.7715  -18.9286
            22  C1a C    12.5690  -18.2212
            23  C1a C    13.7715  -20.3433
BOND        24
            1     2   6 1
            2     2   1 1 #Down
            3     2   3 1
            4     3   4 2
            5     3   5 1
            6     1   7 1
            7     7   8 2
            8     8   9 1
            9     9  10 2
            10   10  11 1
            11   11  12 2
            12    7  12 1
            13    6  13 1
            14   14  13 1 #Down
            15   13  15 2
            16   14  16 1
            17   16  17 1
            18   17  18 1
            19   18  19 1
            20   19  20 1
            21   14  20 1
            22   18  21 1 #Up
            23   21  22 1
            24   21  23 1
///
